Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Catalyst Pharmaceuticals, Inc. Transaction History

Empirical Financial Services, LLC D.B.A. Empirical Wealth Management

$3.31 Billion
Q1 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 02, 2022	SELL	$6.23 - $8.57 $152,846 - $210,256	-24,534 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $66,502 - $104,074	12,524 Added 104.28%	24,534 $203,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $62,572 - $89,474	12,010 New	12,010 $81,000

Others Institutions Holding CPRX

# of Institutions

277

Shares Held

95.7M

Call Options Held

40.6K

Put Options Held

67.2K

Black Rock Inc. New York, NY

17.7M
Shares

$271 Million
0.01% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

9.13M
Shares

$140 Million
3.01% of portfolio
State Street Corp Boston, MA

8.15M
Shares

$125 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.98M
Shares

$122 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.74M
Shares

$41.9 Million
0.01% of portfolio

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $1.57B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Financial Services, LLC D.B.A. Empirical Wealth Management with notifications on news.

Account